Effect of COVID-19 on Breast Cancer Treatment Examined
More patients with estrogen receptor-positive, HER2-negative breast cancer treated with neoadjuvant endocrine therapy due to COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.